Pieris Pharmaceuticals(PIRS) - 2020 Q3 - Earnings Call Transcript

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q3 2020 Results Conference Call November 4, 2020 8:00 AM ET Company Participants Tom Bures - VP, Finance Steve Yoder - President and CEO Hitto Kaufmann - Chief Scientific Officer Shane Olwill - SVP and Head, Translational Science Conference Call Participants Joseph Thome - Cowen and Company Madhu Kumar - Baird Jonathan Miller - Evercore ISI Matt Phipps - William Blair Sharon Ofer - Sphera Fund Operator Greetings, and welcome to the Pieris Pharmaceuticals Third Quar ...